Phoenix, AZ, September 28, 2026 — A new, non-invasive treatment for recurring liver cancer has demonstrated success in a Gilbert, Arizona patient. Linda Lindquist recently underwent histotripsy, an FDA-approved therapy that utilizes focused ultrasound waves to destroy tumor cells.

The procedure was performed at Banner MD Anderson Cancer Center in Arizona.

Lindquist had been battling liver cancer for 15 years prior to this treatment. She described her recovery as quick and reported feeling as though she had been reborn following the procedure.

Histotripsy is a therapeutic technique that employs focused ultrasound energy to mechanically liquefy and ablate (destroy) targeted tissue. The treatment is non-invasive, meaning it does not require surgical incisions. The FDA approval signifies that the treatment has met the agency’s standards for safety and effectiveness for its intended use.

Details regarding the specific timeline of Lindquist’s treatment or further information about her ongoing medical status were not provided in the summary.

This development offers a potential new avenue for patients with recurring liver cancer who may have limited treatment options or who wish to avoid more invasive procedures. The ability to target and destroy tumors without surgical intervention represents a significant advancement in cancer therapy.

Further information on the widespread availability and long-term outcomes of histotripsy for liver cancer patients is expected as more cases are treated and studied. The success in Lindquist’s case highlights the ongoing innovation in oncological treatments aimed at improving patient recovery and quality of life.

The contractor’s name was not provided. The fine amount was not provided. The permit status was not provided. The inspection outcomes were not provided. The code violations were not provided. What happened next was not provided.

Story summarized from the original created by Micaela Marshall on www.azfamily.com, see more information here.

Media gallery

SignalNewsAI
About The Author